There are a number of clinical trials available to patients newly diagnosed with breast cancer. Clinical trials have the potential to make available to patients cutting edge therapies that may improve outcomes or limit morbidity. Avid participation in breast cancer clinical trials by a generation of brave women before us has allowed the science of treating this disease to advance dramatically. We hope to continue that advancement so that our daughters can enjoy the benefits of more effective and less morbid treatments. The following are some of the trials that are currently open and available locally:
B35 - for patient with Ductal carcinoma in situ (DCIS) undergoing breast preserving surgery and radiation This trial compares tamoxifen to ananstrozole (Arimidex).
MA27 - For post-menopausal patients with estrogen receptor positive breat cancer This trial compares 2 different aromatase inhibitors, exemestane and anastazole (Arimidex). N00C9 - For any patient undergoing chemotherapy This trial tests the use of Ginko Biloba for prevention of cognitive disfunction.
N03CC - For patients taking letrazole (Femara) after tamoxifen This trial tests the use of immediate versus delayed use of zeledronic acid to prevent bone loss. N02C1 - For pre-menopausal patients undergoing chemotherapy This trial tests the use of actonel to help prevent bone loss.